Applied Therapeutics (APLT) Competitors $0.33 -0.04 (-11.06%) Closing price 04:00 PM EasternExtended Trading$0.33 0.00 (-0.37%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLT vs. ACIU, PRME, NBTX, FULC, MOLN, DBVT, DERM, TNGX, TARA, and ACTUShould you be buying Applied Therapeutics stock or one of its competitors? The main competitors of Applied Therapeutics include AC Immune (ACIU), Prime Medicine (PRME), Nanobiotix (NBTX), Fulcrum Therapeutics (FULC), Molecular Partners (MOLN), DBV Technologies (DBVT), Journey Medical (DERM), Tango Therapeutics (TNGX), Protara Therapeutics (TARA), and Actuate Therapeutics (ACTU). These companies are all part of the "pharmaceutical products" industry. Applied Therapeutics vs. AC Immune Prime Medicine Nanobiotix Fulcrum Therapeutics Molecular Partners DBV Technologies Journey Medical Tango Therapeutics Protara Therapeutics Actuate Therapeutics AC Immune (NASDAQ:ACIU) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, community ranking, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations. Is ACIU or APLT more profitable? AC Immune's return on equity of -28.26% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets AC ImmuneN/A -28.26% -18.98% Applied Therapeutics N/A -260.75%-76.04% Does the media favor ACIU or APLT? In the previous week, Applied Therapeutics had 4 more articles in the media than AC Immune. MarketBeat recorded 6 mentions for Applied Therapeutics and 2 mentions for AC Immune. AC Immune's average media sentiment score of 1.89 beat Applied Therapeutics' score of 1.47 indicating that AC Immune is being referred to more favorably in the media. Company Overall Sentiment AC Immune Very Positive Applied Therapeutics Positive Do analysts rate ACIU or APLT? AC Immune currently has a consensus price target of $12.00, suggesting a potential upside of 694.70%. Applied Therapeutics has a consensus price target of $6.10, suggesting a potential upside of 1,758.62%. Given Applied Therapeutics' higher probable upside, analysts plainly believe Applied Therapeutics is more favorable than AC Immune.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AC Immune 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has stronger earnings & valuation, ACIU or APLT? AC Immune has higher revenue and earnings than Applied Therapeutics. AC Immune is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAC Immune$27.31M5.55-$60.41M-$0.58-2.60Applied Therapeutics-$212K-180.13-$119.76M-$1.61-0.20 Does the MarketBeat Community prefer ACIU or APLT? AC Immune received 180 more outperform votes than Applied Therapeutics when rated by MarketBeat users. Likewise, 62.65% of users gave AC Immune an outperform vote while only 57.55% of users gave Applied Therapeutics an outperform vote. CompanyUnderperformOutperformAC ImmuneOutperform Votes26062.65% Underperform Votes15537.35% Applied TherapeuticsOutperform Votes8057.55% Underperform Votes5942.45% Do institutionals & insiders believe in ACIU or APLT? 51.4% of AC Immune shares are held by institutional investors. Comparatively, 98.3% of Applied Therapeutics shares are held by institutional investors. 4.6% of AC Immune shares are held by company insiders. Comparatively, 8.6% of Applied Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, ACIU or APLT? AC Immune has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.88, indicating that its stock price is 88% more volatile than the S&P 500. SummaryAC Immune beats Applied Therapeutics on 10 of the 17 factors compared between the two stocks. Remove Ads Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLT vs. The Competition Export to ExcelMetricApplied TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.19M$6.32B$5.33B$7.57BDividend YieldN/A3.23%5.11%4.33%P/E Ratio-0.206.7921.7317.81Price / Sales-180.13225.93379.1494.58Price / CashN/A65.6738.1534.64Price / Book-1.645.866.464.00Net Income-$119.76M$141.86M$3.20B$247.23M7 Day Performance-5.03%8.98%6.54%7.26%1 Month Performance-36.07%-12.65%-8.55%-6.26%1 Year Performance-93.51%-11.99%10.33%-0.18% Applied Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLTApplied Therapeutics3.9015 of 5 stars$0.33-11.1%$6.10+1,758.6%-92.8%$38.19M$-212,000.00-0.2030Earnings ReportNews CoveragePositive NewsACIUAC Immune2.5215 of 5 stars$1.50-2.0%$12.00+700.0%-44.5%$151.62M$27.31M-3.28140Analyst RevisionGap DownPRMEPrime Medicine2.7882 of 5 stars$1.15-7.7%$13.38+1,059.0%-76.8%$151.49M$2.98M-0.56234NBTXNanobiotix2.4857 of 5 stars$3.21+6.3%$8.00+149.2%-45.3%$151.30M$-11,609,000.000.00100Gap DownHigh Trading VolumeFULCFulcrum Therapeutics2.3174 of 5 stars$2.78-3.5%$8.63+210.3%-61.1%$151.14M$80M-9.03100Short Interest ↓Positive NewsGap DownMOLNMolecular Partners2.4275 of 5 stars$3.77-1.5%$12.00+218.0%-2.3%$148.58M$4.97M-1.71180Upcoming EarningsDBVTDBV Technologies2.6077 of 5 stars$7.17+1.4%$22.50+213.8%+12.2%$147.48M$15.73M-1.5980Earnings ReportAnalyst ForecastShort Interest ↑Gap DownDERMJourney Medical2.3943 of 5 stars$6.39-2.3%$9.88+54.5%+40.5%$146.94M$56.13M-6.7790Short Interest ↑Positive NewsGap UpTNGXTango Therapeutics1.8885 of 5 stars$1.28-9.6%$12.33+867.3%-81.8%$144.87M$42.07M-1.1490Analyst ForecastAnalyst RevisionNews CoverageTARAProtara Therapeutics1.9879 of 5 stars$3.65-8.8%$22.50+516.4%+38.0%$144.86MN/A-1.4030Positive NewsACTUActuate TherapeuticsN/A$7.40+0.1%$20.00+170.3%N/A$144.54MN/A0.0010 Remove Ads Related Companies and Tools Related Companies AC Immune Alternatives Prime Medicine Alternatives Nanobiotix Alternatives Fulcrum Therapeutics Alternatives Molecular Partners Alternatives DBV Technologies Alternatives Journey Medical Alternatives Tango Therapeutics Alternatives Protara Therapeutics Alternatives Actuate Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
